← Back to Search

nfant(R) feeding system for Premature Infants

N/A
Waitlist Available
Led By Nanette Gremillion, PT, MS, CNT
Research Sponsored by Woman's
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 33 weeks through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial is testing whether using high-tech monitors during feedings for premature babies will help improve feeding performance and clinical decision making.

Eligible Conditions
  • Premature Infants
  • Premature Birth

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~33 weeks through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 33 weeks through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of inpatient Modified Barium Swallow Study (MBSS)/repeat MBSS
Number of participants with Full oral feeding
Number of participants with decreased Feeding Related Length of Stay
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: nfant(R) feeding systemExperimental Treatment1 Intervention
Addition of nfant(R) technology, along with visual assessments and cue-based feeding practices, to facilitate an infant's progression to full oral feeding and potentially improve developmentally supportive feeding practices.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
nfant(R) feeding system
2020
N/A
~30

Find a Location

Who is running the clinical trial?

NFANT LabsUNKNOWN
Woman'sLead Sponsor
17 Previous Clinical Trials
1,431 Total Patients Enrolled
Nanette Gremillion, PT, MS, CNTPrincipal InvestigatorWoman's Hospital, Louisiana

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I register to take part in this experiment?

"This clinical trial seeks 50 neonates born between 22 and 29 weeks gestation. To be eligible, the infants must have been no more than 29 6/7 weeks in utero at birth."

Answered by AI

Does this research endeavor accept participants who are aged 40 and above?

"According to the rules regulating this clinical trial, only individuals between 22 and 29 Weeks of age are allowed to participate."

Answered by AI

Is recruitment for this research endeavor currently underway?

"According to clinicaltrials.gov, this particular trail is not presently recruiting participants as the last update was on May 4th 2022. Nonetheless, 287 other trials are actively seeking enrolment at this time."

Answered by AI
~4 spots leftby Apr 2025